Empirical Asset Management LLC Invests $773,000 in Synopsys, Inc. $SNPS

Empirical Asset Management LLC bought a new stake in shares of Synopsys, Inc. (NASDAQ:SNPS) during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund bought 1,567 shares of the semiconductor company’s stock, valued at approximately $773,000.

A number of other hedge funds have also made changes to their positions in the stock. Brighton Jones LLC increased its stake in shares of Synopsys by 5.7% in the fourth quarter. Brighton Jones LLC now owns 921 shares of the semiconductor company’s stock worth $447,000 after acquiring an additional 50 shares during the last quarter. Integrated Wealth Concepts LLC increased its holdings in Synopsys by 11.6% in the first quarter. Integrated Wealth Concepts LLC now owns 760 shares of the semiconductor company’s stock worth $326,000 after buying an additional 79 shares during the last quarter. NewEdge Advisors LLC lifted its stake in Synopsys by 15.1% in the first quarter. NewEdge Advisors LLC now owns 3,010 shares of the semiconductor company’s stock valued at $1,291,000 after acquiring an additional 395 shares during the last quarter. AlphaQuest LLC grew its position in Synopsys by 423.1% in the second quarter. AlphaQuest LLC now owns 68 shares of the semiconductor company’s stock worth $35,000 after acquiring an additional 55 shares in the last quarter. Finally, Envestnet Asset Management Inc. increased its stake in shares of Synopsys by 18.8% during the 2nd quarter. Envestnet Asset Management Inc. now owns 293,042 shares of the semiconductor company’s stock worth $150,237,000 after purchasing an additional 46,427 shares during the last quarter. 85.47% of the stock is owned by hedge funds and other institutional investors.

Key Headlines Impacting Synopsys

Here are the key news stories impacting Synopsys this week:

• Positive Sentiment: Q1 beat and strong results — Synopsys reported non‑GAAP EPS of $3.77 and revenue of $2.409B, topping estimates and showing strong year‑over‑year growth; the quarter came at the high end of prior guidance. PR Newswire: Q1 Results
• Positive Sentiment: Very bullish guidance — management raised FY26 EPS guidance to $14.38–$14.46 and Q2 EPS guidance to $3.11–$3.17, well above Street estimates, which is driving optimism about near‑term earnings power. Guidance/Press Release
• Positive Sentiment: Capital return boost — the board authorized up to $2.0B in additional share repurchases, which supports EPS and signals confidence from management. Buyback Announcement
• Positive Sentiment: Analyst and market interest — Morgan Stanley reiterated a Buy and noted strong earnings quality and IP trajectory; unusual call‑option buying also points to bullish trader positioning. TipRanks: Morgan Stanley Buy
• Neutral Sentiment: Mixed near‑term revenue signal — while EPS guidance was raised, quarterly revenue guidance landed roughly in line with expectations, suggesting upside is currently EPS‑driven rather than revenue surprise. Guidance Details
• Negative Sentiment: China export restrictions and muted next‑quarter outlook — Reuters flagged Synopsys forecasting a more muted quarter amid China export limits and macro uncertainty, which pressured the stock earlier and could cap upside if geopolitical risk persists. Reuters: China Export Restrictions
• Negative Sentiment: Leverage concerns from M&A — commentators note Synopsys carries large incremental debt (post‑deal) that investors are watching closely; higher leverage raises sensitivity to execution and could limit valuation expansion. 24/7 Wall St.: Debt Concerns

Synopsys Price Performance

Shares of NASDAQ:SNPS opened at $449.17 on Thursday. The company has a market cap of $86.04 billion, a price-to-earnings ratio of 56.22, a PEG ratio of 3.67 and a beta of 1.12. The business has a 50 day moving average price of $472.85 and a 200 day moving average price of $479.02. The company has a quick ratio of 1.52, a current ratio of 1.62 and a debt-to-equity ratio of 0.48. Synopsys, Inc. has a twelve month low of $365.74 and a twelve month high of $651.73.

Synopsys (NASDAQ:SNPS) last issued its quarterly earnings results on Wednesday, February 25th. The semiconductor company reported $3.77 EPS for the quarter, topping analysts’ consensus estimates of $3.56 by $0.21. The company had revenue of $2.41 billion during the quarter, compared to analyst estimates of $2.39 billion. Synopsys had a return on equity of 7.89% and a net margin of 18.89%.The company’s quarterly revenue was up 65.6% compared to the same quarter last year. During the same period in the previous year, the company earned $3.03 earnings per share. Synopsys has set its FY 2026 guidance at 14.380-14.460 EPS and its Q2 2026 guidance at 3.110-3.170 EPS. Research analysts predict that Synopsys, Inc. will post 10.64 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of research firms have recently weighed in on SNPS. Wells Fargo & Company raised their price target on shares of Synopsys from $445.00 to $500.00 and gave the company an “equal weight” rating in a report on Thursday, December 11th. Bank of America upgraded Synopsys from an “underperform” rating to a “neutral” rating and decreased their price target for the stock from $525.00 to $500.00 in a research note on Monday, December 8th. Morgan Stanley reissued an “overweight” rating on shares of Synopsys in a research note on Wednesday. The Goldman Sachs Group set a $600.00 target price on Synopsys and gave the stock a “buy” rating in a report on Wednesday. Finally, KeyCorp upped their target price on Synopsys from $575.00 to $600.00 and gave the stock an “overweight” rating in a research report on Thursday, December 11th. Nine research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, Synopsys presently has a consensus rating of “Hold” and an average price target of $547.00.

Insiders Place Their Bets

In other Synopsys news, CFO Shelagh Glaser sold 3,657 shares of the firm’s stock in a transaction on Friday, December 19th. The shares were sold at an average price of $460.77, for a total value of $1,685,035.89. Following the sale, the chief financial officer directly owned 17,842 shares in the company, valued at $8,221,058.34. This trade represents a 17.01% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider Janet Lee sold 250 shares of the business’s stock in a transaction dated Monday, January 12th. The stock was sold at an average price of $530.00, for a total transaction of $132,500.00. Following the transaction, the insider owned 11,959 shares in the company, valued at approximately $6,338,270. The trade was a 2.05% decrease in their position. The SEC filing for this sale provides additional information. Over the last three months, insiders sold 4,157 shares of company stock valued at $1,945,036. Insiders own 0.62% of the company’s stock.

Synopsys Company Profile

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.